LANGERHANS' CELL GRANULOMA CONFINED TO THE BILE DUCT

Langerhans' cell histiocytosis (LCH) of the liver is uncommon. When seen, it is part of multifocal disease and can present as biliary obstruction. We present a case of sclerosing biliary disease with a solitary LCH lesion and no evidence of systemic disease. We postulate that the LCH is a secondary phenomenon, arising against a background of a complex, familial liver disease. This case also raises the possibility that some instances of idiopathic sclerosing cholangitis may follow cryptic LCH of the bile ducts.     

RENAL MEDULLARY CARCINOMA: A Potential Sickle Cell Nephropathy of Children and Adolescents

An extremely aggressive malignant epithelial neoplasm of the kidney has recently been described and named renal medullary carcinoma. The finding of this tumor is highly predictive of drepanocytes (sickle cells) in tissue sections and thus the presence of sickle hemoglobin, specifically sickle cell trait, in the patient. We present a case report of this rare tumor in a 10-year-old male. The tumor displayed a variable histologic architecture including gland-like areas with intra- and extracytoplasmic material resembling mucin with hematoxylin and eosin stain. This material was negative with periodic acid-Schiff and mucicarmine stains, stained only weakly with Alcian Blue, and was positive using antibodies against peanut agglutinin. Tumor cells stained positively with antibodies to epithelial membrane antigen, cytokeratin, vimentin, and Ulex europaeus lectin. The luminal face of tumor cells stained with peanut agglutinin. Stains using antibodies against carcinoembryonic antigen and alpha-fetoprotein were negative. Ultrastructurally, the tumor cells were characterized by short microvilli lining the luminal surface and lateral complex infoldings of adjacent plasma membranes. We discuss the relationship of this neoplasm to another renal pelvic neoplasm, collecting duct carcinoma, which may rarely occur in children. Renal medullary carcinoma should be included in the differential diagnosis of gross hematuria, which is most commonly benign self-limited hematuria, in young patients with sickle cell trait.     

Enhancement of Radiation Response by Paclitaxel in Mice According to Different Treatment Schedules

Purpose: The aim of our study was to determine if paclitaxel could be used as a radiosensitizer in vivo.

Materials and methods: Paclitaxel was tested as a single agent and combined with an X-ray treatment. Paclitaxel was administered i.p. in doses from 30 to 120 mg/kg b.w. to (C3D2F1) mice bearing spontaneous mammary carcinoma. Tumor growth delay (TGD) or tumor control dose (TCD₅₀, radiation dose needed to induce local tumor control in 50% of irradiated animals) and moist desquamation dose (MDD₅₀, radiation dose needed to induce serious moist desquamation in 50% of the non-tumor-bearing feet) were the endpoints. DNA flow cytometric analysis was performed.

Results: DNA analysis demonstrated a G2/M block of tumor cells and a depletion of cells in S phase, with a maximum at 24 h from paclitaxel administration. Administering paclitaxel, in graded doses, 15 min before a 10-Gy X-ray treatment resulted in a linear regression line, almost parallel to that with paclitaxel alone, with a growth delay of about 6 days. In contrast, varying the X-ray dose with a constant paclitaxel injection (45 mg/kg b.w.) treatment showed some degree of synergism as the linear regression curves diverged. Interval time and sequence between paclitaxel administration and a 10 Gy X-ray treatment did not influence TGD. Protocols with paclitaxel at 30, 45, or 60 mg/kg were combined with radiation treatments at various doses (from 10 to 65 Gy). Values of TCD50 varied from 50.8 Gy for X-ray alone to 31.8 Gy for paclitaxel 60 mg/kg + X-ray. No differences were observed among MDD of different protocols.

Conclusions: These results suggest that, under some conditions, paclitaxel combined with radiation can show superadditive effects and this result combined with the lack of severe normal tissue damage indicate that a favorable therapeutic gain can be obtained.     

金属支架联合立体定向适形放疗治疗肝门部胆管癌

目的评价金属支架联合立体定向适形放疗肝门部胆管癌的疗效。方法31例肝门部胆管癌患者行金属支架置入联合立体定向适形放疗,并与23例行单纯支架治疗者进行对比研究。结果联合治疗组生存时间平均为11.1个月;对照组为5.1个月,差异有显著性意义(P<0.01)。结论胆道金属支架置入联合立体定向适形放疗是不能手术肝门部胆管癌的一种有效治疗方法。     

鼻泪管黏膜相关淋巴组织形态学分析

目的 :探讨鼻泪管黏膜相关淋巴组织的组织学特点 ,初步揭示泪道炎症不易治愈的局部原因。方法 :通过常规苏木精 伊红染色 ,利用图像分析仪对兔鼻泪管、鼻腔、咽腔和气管黏膜中的淋巴滤泡发育情况 ,高内皮静脉 (HEV)的分布情况及其周围淋巴细胞浸润的密度进行分析。结果 :鼻泪管黏膜组织中淋巴滤泡和HEV的数量及其周围淋巴细胞浸润的程度均低于鼻腔、咽腔和气管黏膜 (P <0 .0 1)。结论 :正常情况下鼻泪管黏膜的局部免疫反应程度低于鼻腔、咽腔和气管黏膜 ,其黏膜下淋巴组织欠发达可能是泪道炎症不易治愈的主要原因。     

Experimental study on inhibitory effect of bridgy duct of hepatic artery on apoptosis of liver and bile duct cells

Objective： To investigate whether the method of bridgy duct established between the recipient＇s spleen artery and the donor＇s gastroduodenal artery could inhibit the apoptosis of liver and bile duct cells caused by hepatic artery ischemia. Methods： Twenty-four mongrel dogs from Xi＇an area were used to establish simplified models of dog orthotopic liver transplantation and divided into three groups randomly： HAI group （hepatic artery ischemia group）,BBB group（bypassing the blood by a bridgy duct） and control group. After cold perfusion, The samples were collected from liver and bile duct in each group at different time and fixed in glutaraldehyde and 4% polyformaldehyde respectively. At last, the apoptosis of liver and bile duct cells were observed and the apoptotic indexes were calculated. Results： Two hours after cold perfusion, apoptotic phenomenon was common in HAI group, rare in BBB group, while no apoptotic phenomenon was observed in control group. TUNEL staining showed that there was no significant difference in apoptotic index among the three groups immediately after cold perfusion. However, with time going, the apoptotic cells were increased in three groups, and the difference in apoptotic index was significant among three groups （P 〈 0.01 ）. Conclusions： Bridgy duct of hepatic artery can inhibit the apoptosis of liver and bile duct cells caused by HAI significantly.     

An epidemiological study on patients undergoing dacryocystorhinostomy

Dacryocystorhinostomy is performed in patients with naso-lacrimal duct obstruction to bypass the site of obstruction so as to relieve the patient of the irritating and socially embarrassing symptoms of epiphora. We discuss the various epidemiological aspects especially the vast difference by which the females out-number the males in patients undergoing DCR and the likely explanations for this difference in our study on 74 patients which underwent DCR in our institute.     

新辅助化疗应用于局部晚期乳腺癌的疗效分析

目的探讨术前新辅助化疗对乳腺癌的疗效及提高患者术后生存率的作用.方法采用CMF和CAF两种化疗方案对50例Ⅲ期乳腺癌术前患者(A组)进行化疗,评价其疗效;与术后化疗(B组)进行总疗效对照比较.结果术前新辅助化疗组经化疗肿瘤全消和部分消退合计总有效率为58.0%;术后随访5 a生存率、无瘤存活率明显高于对照B组,两组无瘤存活率比较χ2＝9.07,P＜0.01.结论术前全身治疗(化疗)作为乳腺癌第一步治疗可能是首先使已存在的临床小转移灶得以控制,进而获得更多治疗成功的机会.     

Anterior abdominal wall defects and biliary obstruction

Three infants with anterior abdominal wall defects (gastroschisis and exomphalos) who presented with obstructive jaundice secondary to biliary obstruction, are described. All three infants had abnormal biliary systems, with mechanical distortion of the biliary tree. Biliary obstruction secondary to structural biliary anomalies should be considered in patients with abdominal wall defects and cholestasis, as prolonged unrelieved biliary obstruction may lead to biliary cirrhosis and portal hypertension.     

引线硅胶管植入术治疗单纯泪小点狭窄或闭锁的疗效观察

目的:观察引线硅胶管植入术治疗单纯泪小点狭窄或闭锁的临床疗效。方法:单纯泪小点狭窄或闭锁患者42例72眼,按照年龄分成60岁以上及以下两组。局部麻醉下行引线硅胶管植入术,术后给予局部消炎抗感染治疗。术后冲洗泪道1次/wk,共4次,1～3mo后拔管,计算治愈率,并行卡方检验。结果:所有患者术中均成功植入引线硅胶管。平均观察14mo。治愈59眼(82%),好转8眼(11%),无效5眼(7%)。60岁以上组治愈率、有效率均较60岁以下组低。结论:引线硅胶管植入术治疗单纯泪小点狭窄或闭锁,操作简便、创伤小、效果好、值得临床推广。